We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
DB:TKD
​
​
logo

Takeda Pharmaceutical Company Limited (TKD)

DB • TKD • JP3463000004

Ex-dividend 30 Mar 27 · 102 JPY (special)
37.00Last close
Market Closed
Ex-dividend 30 Mar 27 · 102 JPY (special)
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 0.1% of free float is sold short, 2,319 days to cover, cost to borrow 0.73%.

Market Cap

66.3b USD | # 357 in DE

Volume

441 shares | 15.59k USD

Shares Outstanding

1.6b

Free Float Shares

96.86% | 1.55b

NYSE:TAK|
OTCPK:TKPH.F|
DB:TKDA|
LSE:0A87|
TSE:4502|
BOVESPA:TAKP34|
WBAG:TKD

News

TKD key data

Takeda Pharmaceutical Company Limited (DB: TKD) has a market capitalization of $66.3B. Last close €37.00 (as of 2026-11-05); 52-week range €23.01 to €37.40. ORTEX data as of 2026-11-03: short interest is 0.1% of free float, 2,319 days to cover and the average cost to borrow is 0.73%.

  • TKD news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.